264 related articles for article (PubMed ID: 21863885)
21. Antitumor activity of sugar-modified cytosine nucleosides.
Matsuda A; Sasaki T
Cancer Sci; 2004 Feb; 95(2):105-11. PubMed ID: 14965358
[TBL] [Abstract][Full Text] [Related]
22. Gemcitabine: a critical nucleoside for cancer therapy.
Gesto DS; Cerqueira NM; Fernandes PA; Ramos MJ
Curr Med Chem; 2012; 19(7):1076-87. PubMed ID: 22257063
[TBL] [Abstract][Full Text] [Related]
23. Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs.
Vinogradov SV; Zeman AD; Batrakova EV; Kabanov AV
J Control Release; 2005 Sep; 107(1):143-57. PubMed ID: 16039001
[TBL] [Abstract][Full Text] [Related]
24. Targeted delivery to PEPT1-overexpressing cells: acidic, basic, and secondary floxuridine amino acid ester prodrugs.
Landowski CP; Vig BS; Song X; Amidon GL
Mol Cancer Ther; 2005 Apr; 4(4):659-67. PubMed ID: 15827340
[TBL] [Abstract][Full Text] [Related]
25. Bifunctional and Unusual Amino Acid β- or γ-Ester Prodrugs of Nucleoside Analogues for Improved Affinity to ATB
Sun Y; Ke Y; Li C; Wang J; Tu L; Hu L; Jin Y; Chen H; Gong J; Yu Z
J Med Chem; 2020 Oct; 63(19):10816-10828. PubMed ID: 32882127
[TBL] [Abstract][Full Text] [Related]
26. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier.
Li M; Liang Z; Sun X; Gong T; Zhang Z
PLoS One; 2014; 9(11):e112888. PubMed ID: 25389968
[TBL] [Abstract][Full Text] [Related]
27. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
[TBL] [Abstract][Full Text] [Related]
28. Lipophilic Triphosphate Prodrugs of Various Nucleoside Analogues.
Jia X; Schols D; Meier C
J Med Chem; 2020 Jul; 63(13):6991-7007. PubMed ID: 32515595
[TBL] [Abstract][Full Text] [Related]
29. Parallel G-quadruplex Structures Increase Cellular Uptake and Cytotoxicity of 5-Fluoro-2'-deoxyuridine Oligomers in 5-Fluorouracil Resistant Cells.
Clua A; Fàbrega C; García-Chica J; Grijalvo S; Eritja R
Molecules; 2021 Mar; 26(6):. PubMed ID: 33804620
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo toxicity of 5-FdU-alendronate, a novel cytotoxic bone-seeking duplex drug against bone metastasis.
Schott S; Vallet S; Tower RJ; Noor S; Tiwari S; Schem C; Busch C
Invest New Drugs; 2015 Aug; 33(4):816-26. PubMed ID: 25986684
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-Activated and Indomethacin-Mediated Theranostic Prodrug Releasing Drug On-Demand for Tumor Imaging and Therapy.
Peng X; Gao J; Yuan Y; Liu H; Lei W; Li S; Zhang J; Wang S
Bioconjug Chem; 2019 Nov; 30(11):2828-2843. PubMed ID: 31592652
[TBL] [Abstract][Full Text] [Related]
32. Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound.
Pes L; Koester SD; Magnusson JP; Chercheja S; Medda F; Abu Ajaj K; Rognan D; Daum S; Nollmann FI; Garcia Fernandez J; Perez Galan P; Walter HK; Warnecke A; Kratz F
J Control Release; 2019 Feb; 296():81-92. PubMed ID: 30639692
[TBL] [Abstract][Full Text] [Related]
33. Mutual Prodrugs of 5-Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs.
Ciaffaglione V; Modica MN; Pittalà V; Romeo G; Salerno L; Intagliata S
ChemMedChem; 2021 Dec; 16(23):3496-3512. PubMed ID: 34415107
[TBL] [Abstract][Full Text] [Related]
34. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
[TBL] [Abstract][Full Text] [Related]
35. Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine.
Arias JL; Reddy LH; Couvreur P
J Drug Target; 2009 Sep; 17(8):586-98. PubMed ID: 19694612
[TBL] [Abstract][Full Text] [Related]
36. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.
Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P
Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442
[TBL] [Abstract][Full Text] [Related]
37. Bis(benzoyloxybenzyl)-DiPPro nucleoside diphosphates of anti-HIV active nucleoside analogues.
Weinschenk L; Gollnest T; Schols D; Balzarini J; Meier C
ChemMedChem; 2015 May; 10(5):891-900. PubMed ID: 25847660
[TBL] [Abstract][Full Text] [Related]
38. Lipophilic prodrugs and formulations of conventional (deoxy)nucleoside and fluoropyrimidine analogs in cancer.
Peters GJ; Adema AD; Bijnsdorp IV; Sandvold ML
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1168-80. PubMed ID: 22132972
[TBL] [Abstract][Full Text] [Related]
39. Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.
Lang TT; Selner M; Young JD; Cass CE
Mol Pharmacol; 2001 Nov; 60(5):1143-52. PubMed ID: 11641443
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of aryloxy thiophosphoramidate triesters of anticancer nucleoside analogues.
Serpi M; di Ciano S; Pertusati F
Bioorg Med Chem; 2024 Apr; 103():117696. PubMed ID: 38547648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]